62(top 2%)
papers
3.9K(top 1%)
citations
31(top 1%)
h-index
61(top 1%)
g-index
66
all documents
4.1K
doc citations
767
citing journals

Top Articles

#TitleJournalYearCitations
1European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 updateAnnals of the Rheumatic Diseases2016743
2Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisNature Genetics2010334
3A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritisAnnals of the Rheumatic Diseases2012234
4Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativaBritish Journal of Dermatology2015220
5Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differBritish Journal of Rheumatology1996208
6Development of a preliminary composite disease activity index in psoriatic arthritisAnnals of the Rheumatic Diseases2011184
7Synovial tissue macrophages and joint erosion in rheumatoid arthritis.Annals of the Rheumatic Diseases1994163
8Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritisNature Communications2015149
9Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?Seminars in Arthritis and Rheumatism2016119
10Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritisAnnals of the Rheumatic Diseases2011103
11IMMUNOHISTOLOGICAL FEATURES IN THE SYNOVIUM OBTAINED FROM CLINICALLY UNINVOLVED KNEE JOINTS OF PATIENTS WITH RHEUMATOID ARTHRITISRheumatology198984
12Remission in psoriatic arthritis: is it possible and how can it be predicted?Arthritis Research and Therapy201077
13Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritisArthritis and Rheumatism198972
14Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysisRheumatology199869
15PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locusAnnals of the Rheumatic Diseases201564
16Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targetingBest Practice and Research in Clinical Rheumatology200663
17Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid ArthritisPLoS ONE201162
18Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritisAnnals of the Rheumatic Diseases201157
19Application of composite disease activity scores in psoriatic arthritis to the PRESTA data setAnnals of the Rheumatic Diseases201257
20Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesisCurrent Rheumatology Reports200552
21Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical NeedsClinical Reviews in Allergy and Immunology201852
22Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisAnnals of the Rheumatic Diseases201751
23A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiativeSeminars in Arthritis and Rheumatism201850
24Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitisClinical Rheumatology202050
25Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centersJournal of Rheumatology200750
26Lymphedema of the upper limb in patients with psoriatic arthritisSeminars in Arthritis and Rheumatism199346
27Analysis of cell populations in rheumatoid arthritis synovial tissuesSeminars in Arthritis and Rheumatism199240
28Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposureRMD Open201540
29Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritisAnnals of the Rheumatic Diseases201036
30Contrasting levels ofin vitrocytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltrationClinical and Experimental Immunology200834
314-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritisRMD Open201834
32Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trialJournal of the European Academy of Dermatology and Venereology201131
33Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyArthritis Research and Therapy201830
34Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locusRheumatology202030
35Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis.Annals of the Rheumatic Diseases199129
36Interleukin 15 Primes Natural Killer Cells to Kill via NKG2D and cPLA2 and This Pathway Is Active in Psoriatic ArthritisPLoS ONE201328
37Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in EuropeansPLoS ONE201327
38Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 radsArthritis and Rheumatism198926
39C5orf30 is a negative regulator of tissue damage in rheumatoid arthritisProceedings of the National Academy of Sciences of the United States of America201526
40A clinically based protein discovery strategy to identify potential biomarkers of response to anti‐TNF‐α treatment of psoriatic arthritisProteomics - Clinical Applications201626
41Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingJournal of Rheumatology201624
42Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discoveryProteomics - Clinical Applications201621
43New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the diseaseJournal of the European Academy of Dermatology and Venereology201420
44Implications of the diversity of class I HLA associations in psoriatic arthritisClinical Immunology201619
45Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxisJournal of Thrombosis and Haemostasis202218
46Remission in psoriatic arthritis—where are we now?Rheumatology201816
47The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measuresJournal of Rheumatology199613
48Assessment of cognitive function in patients with systemic lupus erythematosusIrish Journal of Medical Science19939
49Adhesion molecule in untreated inflammatory arthritisQJM - Monthly Journal of the Association of Physicians19969
50Building Bridges between Researchers and Patient Research Partners: A Report from the GRAPPA 2014 Annual MeetingJournal of Rheumatology20159